Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)-Reference-Cited by-同舟云学术

Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)

Published:2017-12 Issue:12 Volume:12 Page:1766-1778
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Zhong Jia,Li Lei,Wang Zhijie,Bai Hua,Gai Fei,Duan Jianchun,Zhao Jun,Zhuo Minglei,Wang Yuyan,Wang Shuhang,Zang Wanchun,Wu Meina,An Tongtong,Rao Guanhua,Zhu Guanshan,Wang Jie

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference56 articles.

1. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012

2. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

4. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N Engl J Med,2005

5. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling;Engelman;Science,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease;Cell Biology and Toxicology;2024-09-14

2. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors;Future Medicinal Chemistry;2024-08-29

3. MYC expression and fatty acid oxidation in EGFR-TKI acquired resistance;Drug Resistance Updates;2024-01

4. Oncogenèse pulmonaire et bases biologiques des traitements ciblés;Revue des Maladies Respiratoires Actualités;2023-10

5. Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions;Frontiers of Medicine;2023-02